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ABSTRACT
Objective: The objective of the present study was to develop solid self-microemulsifying drug delivery system (S-SMEDDS) of diacerein (DCN) for 
enhancement of dissolution rate.
Methods: Three batches of liquid SMEDDS were prepared using oleic acid, Tween 80, and polyethylene glycol 200 as oil, surfactant, and cosurfactant, 
respectively. Microemulsion region was recognized by constructing a pseudoternary phase diagram containing a different proportion of oil, surfactant, 
and cosurfactant. Prepared liquid SMEDDS was evaluated for thermodynamic stability study, dispersibility tests, globule size, zeta potential, and 
viscosity. Liquid SMEDDS was then converted to S-SMEDDS by adsorption technique using Neusilin US2 as a solid carrier. Prepared S-SMEDDS was 
evaluated for different micromeritic properties, drug content, reconstitution properties, in vitro dissolution study, Fourier transform infrared, and 
scanning electron microscopy.
Results: The results showed that all batches of liquid SMEDDS were found to be thermodynamically stable. Reconstitution properties of S-SMEDDS 
showed spontaneous microemulsification with globule size 0.271 µm and −16.18 mV zeta potential. From the results of in vitro dissolution study, it 
was found that the release of DCN was significantly increased as compared with plain DCN.
Conclusion: The study concluded that dissolution rate of poorly water-soluble drug like DCN can be increased by developing S-SMEDDS formulation.
Keywords: Diacerein, In vitro dissolution study, Neusilin US2, Pseudoternary phase diagram, Self-microemulsifying drug delivery system.
INTRODUCTION
Oral drug delivery is used for many years through different dosage forms 
due to its easy administration and good patient compliance [1]. It has 
been projected that about 70% of new chemical entities (NCE) entering 
drug development programs have poor water solubility to consign 
consistent gastrointestinal absorption in sufficient concentration to 
ensure therapeutic efficacy [2]. Various approaches have been used to 
improve solubility and dissolution rate of the poorly water-soluble drug. 
Among them, self-microemulsifying drug delivery systems (SMEDDSs) 
have shown great promise for enhancing bioavailability of poorly 
soluble compounds [3]. SMEDDSs are isotropic mixtures of drug, lipids, 
and surfactants, usually with one or more hydrophilic cosolvents or 
emulsifiers. On mild agitation followed by dilution with aqueous media, 
these systems can form fine (oil in water) emulsion instantaneously [4]. 
SMEDDSs are generally encapsulated either in hard or soft gelatin capsules. 
Lipid formulations, however, may interact with the capsule resulting in 
either brittleness or softness of the shell [5]. To overcome this problem, 
SMEDDSs need to convert into solid SMEDDS (S-SMEDDS). The major 
techniques for converting SMEDDS to S-SMEDDS are spray cooling, spray 
drying, adsorption onto solid carriers, melt granulation, melt extrusion, 
supercritical fluid-based methods, and high-pressure homogenization. 
However, the adsorption process is simple and involves simple addition 
of the liquid formulation to solid carriers by mixing in a blender [6]. 
Neusilin US2 is a fine ultra-light granule of magnesium aluminometasilicate 
and is widely accepted as a multifunctional excipient that improves the 
quality of pharmaceuticals. Due to its large surface area and porous nature, 
Neusilin US2 adsorbs high loads of oils or water and can be mechanically 
compacted into high-quality tablets. It exhibits high adsorbing capacity and 
can be used to convert SMEDDS to S-SMEDDS [6-9].
Diacerein (DCN) is 4,5-diacetoxy-9,10-dioxo-9,10-dihydroanthracene-
2-carboxylic acid (Fig. 1) and mainly used for the treatment of 
osteoarthritis [10]. It is metabolized to active constituent rhein. 
Rhein is thought to act through inhibition of interleukin-1β and 
proteolytic enzymes along with which it stimulates the synthesis of 
cartilage components and modifies the understanding of pathological 
conditions [11]. As it does not inhibit the synthesis of prostaglandins, 
it is emerging, better and safe therapeutic agent as compared 
to NSAIDs [12]. It is used in treating rheumatoid arthritis and 
osteoarthritis. DCN aqueous solubility is 7–10 µg/ml at pH 7.0 and 
at 40°C. After oral administration, the peak plasma concentration is 
reported 2.2 h with even distribution in vivo and volume of distribution 
of 13.2 L in humans [13]. The poor solubility and wettability of DCN 
give rise to difficulties in pharmaceutical formulation meant for oral 
administration, which may lead to variation in bioavailability [14]. The 
present study was aimed to develop S-SMEDDS of DCN for enhanced 
solubility and dissolution rate.
MATERIALS AND METHODS
Materials
DCN was obtained as a gift sample from Virdev Intermediates Pvt., Ltd., 
Palsana, Surat, India. Neusilin US2 was gifted by Fuji Chemicals, Japan. 
Oleic acid was obtained from Loba Chemie Pvt., Ltd., Mumbai. Tween 80 
and polyethylene glycol 200 (PEG 200) were obtained from S. D. Fine 
Chem., Mumbai. All other chemicals were of reagent grade.
Methods
Construction of pseudoternary phase diagram
From previous solubility, the study of DCN, oleic acid, Tween 80, and 
PEG 200 was selected as oil, surfactant, and cosurfactant, respectively. 
Hence, as to get stable SMEDDS, microemulsion region was identified 
by constructing pseudoternary phase diagram containing a different 
proportion of surfactant:cosurfactant (km=1:1, 2:1, and 3:1), oil and 
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water. In brief, Smix and oil were mixed at a ratio of 1:9, 2:8, 3:7, 4:6, 
5:5, 6:4, 7:3, 8:2, and 9:1 in a preweighed test tube. To the resultant 
mixtures, double distilled water was added dropwise until the first sign 
of turbidity observed, to identify the endpoint. After equilibrium, if the 
system became clear, then the water addition was continued [6,15].
Preparation of liquid SMEDDS
Pseudoternary phase diagram of km=3 was selected for the formulation 
of liquid SMEDDS as it showed high microemulsion region as compared 
to km=1 and 2. From microemulsion region, three formulation batches 
DCN-L1, DCN-L2, and DCN-L3 were selected. The composition of 
different batches of liquid SMEDDS is shown in Table 1. In brief, DCN 
(500 mg/10 g) was placed in a glass vial. To this, oleic acid was added 
and warmed on a water bath. In this oily mixture, Tween 80 and PEG 
200 in the proportion of 3:1 were added. Then, the components were 
mixed by gentle stirring and vortex mixing at 37°C until DCN was 
completely dissolved. Then, the mixture was sealed in a glass vial and 
stored at room temperature until used [6,16].
Evaluation of liquid SMEDDS [3,6,17,18]
Thermodynamic stability studies
Thermodynamic stability study of prepared liquid SMEDDS was 
determined by carrying a heating-cooling cycle, centrifugation test, and 
freeze-thaw cycle.
Robustness to dilution
Robustness to dilution was studied by diluting liquid SMEDDS to 50, 
100, and 1000 times with water and 0.1 N HCl. The diluted SMEDDSs 
were stored for 12 h and observed for any signs of phase separation or 
drug precipitation.
Assessment of the efficiency of self-emulsification
The efficiency of self-emulsification was assessed by the procedure 
used by Khoo et al. using the United States Pharmacopeia 
(USP) - Type-II dissolution test apparatus (Veego VDA-8DR). 1 mL 
of liquid SMEDDS was added dropwise to 200 ml of 0.1 N HCl at 
37°C. Gentle agitation was provided by a standard stainless steel 
dissolution paddle rotating at 60 rpm. SMEDDS assessed visually 
according to the rate of emulsification and the final appearance of 
the emulsion [18].
Percentage transmittance
About 1 mL of liquid SMEDDS was diluted to 100 mL distilled water 
and observed for any turbidity and percentage transmittance was 
measured at 650 nm using ultraviolet (UV)-visible spectrophotometer 
(Shimadzu-1800, Japan) against distilled water as a blank [19].
Globule size, zeta potential, and viscosity
Liquid SMEDDS was diluted to 10 times with distilled water and globule 
size and zeta potential were determined using Malvern Zetasizer. The 
viscosity of the all formulations was determined as such without 
dilution using Brookfield LVDV II + Pro viscometer using spindle S18 at 
20 rpm at room temperature.
Dye solubilization test
Hence, as to confirm the oil in water nature of SMEDDS a water-soluble 
dye eosin was sprinkled onto the surface of the prepared microemulsion 
and observed for spontaneous dispersion.
Cloud point measurement
Liquid SMEDDS was diluted with distilled water in the ratio of 1:250, 
placed in a water bath and its temperature was increased gradually. 
Cloud point was measured as the temperature at which there was a 
sudden appearance of cloudiness visually.
Formulation of S-SMEDDS
All three batches of liquid SMEDDS (DCN-L1, DCN-L2, and DCN-L3) were 
converted to S-SMEDDS (DCN-S1, DCN-S2, and DCN-S3) by adsorption 
technique using Neusilin US2. S-SMEDDS was prepared by mixing liquid 
SMEDDS containing DCN with Neusilin US2 in 1:1 proportion. In brief, 
liquid SMEDDS was added dropwise over Neusilin US2 contained in a 
broad porcelain dish. After each addition, the mixture was homogenized 
using a glass rod to ensure uniform distribution of formulation [3,6].
Evaluation of S-SMEDDS
Micromeritic properties of S-SMEDDS
Prepared S-SMEDDS was evaluated for micromeritic properties such 
as angle of repose, bulk and tapped density, compressibility index, and 
Hausner ratio [18].
Determination of drug content
Drug content was calculated by dissolving S-SMEDDS equivalent to 
500 mg of DCN into 50 ml measuring cylinder containing phosphate 
buffer of pH 6.8 with 0.03% of SLS and then sonicated for 15 min 
followed by filtered through the Whatman filter paper. It was then 
diluted suitably with phosphate buffer pH 6.8 with 0.03% SLS. The 
absorbance of both standard and sample preparation after appropriate 
dilution was measured in UV spectrophotometer (Shimadzu-1800, 
Japan) at 258 nm using phosphate buffer pH 6.8 with 0.03% SLS [20].
Reconstitution properties of S-SMEDDS
Percentage transmittance, globule size, and zeta potential
Reconstituted S-SMEDDSs were also characterized for percentage 
transmittance, globule size, and zeta potential as described for liquid 
SMEDDS.
In vitro dissolution study
The dissolution study of different SMEDDS formulations and plain DCN 
was determined using a USP - Type I (basket type) apparatus under sink 
condition. The solid SMEDDSs containing 500 mg of DCN were filled 
Fig. 1: Chemical structure of diacerein











DCN-L1 500 10 30 10 40 50
DCN-L2 500 10 37.5 12.5 50 40
DCN-L3 500 10 45 15 60 30
DCN: Diacerein, SMEDDS: Self-microemulsifying drug delivery system, 
PEG 200: Polyethylene glycol 200
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into hard gelatin capsules (capsule no. 00). The dissolution medium was 
900 ml phosphate buffer pH 6.8 with 0.03% SLS at 37±0.5°C at 50 rpm, 
to simulate in vivo conditions. Dissolution study was carried out for 1 h. 
A sample of 5 ml was withdrawn at a predetermined time interval of 5, 
10, 15, 20, 30, 40, 50, and 60 min and filtered through Whatman filter 
paper and replaced by an equal volume of dissolution medium. The 
sample was suitably diluted with phosphate buffer pH 6.8 with 0.03% 
SLS, and drug content in the dissolution sample was determined by UV 
spectrophotometer at 258 nm [21].
Fourier transform infrared (FTIR) study of S-SMEDDS
FTIR spectrum was recorded for DCN, a physical mixture of 
DCN:Neusilin US2 and prepared S-SMEDDS using Agilent Cary 630 FTIR 
spectrometer.
Scanning electron microscopy (SEM)
SEMs for prepared S-SMEDDS were taken using an SEM (JEOL, Japan) at 
accelerating voltage at 3–5 kV to study surface topography.
RESULTS AND DISCUSSION
Identification of the microemulsion region by constructing a 
pseudoternary phase diagram
Constructed pseudoternary phase diagrams are shown in 
Fig. 2a-c. Phase behavior examination of this system established 
an appropriate approach to determine the concentration of oil, 
surfactant:cosurfactant and water so that transparent, monophasic 
low viscous microemulsion can be formed. Phase diagram of km=3 
showed maximum microemulsion region. Hence, it was selected 
for the development of liquid SMEDDS of DCN. Three points on 
microemulsion region were selected for the formulation of three 
batches of liquid SMEDDS (Fig. 2c). The selected composition of liquid 
SMEDDS is shown in Table 1.
Evaluation of liquid SMEDDS
Thermodynamic stability studies
The results of thermodynamic stability study showed that all 
formulations passed heating-cooling cycle test, hence, further exposed 
to centrifugation test. SMEDDS did not show any phase separation after 
centrifugation test, hence, was taken for a freeze-thaw stress test. After 
the freeze-thaw stress test, it was found that SMEDDS showed good 
stability without phase separation.
Robustness to dilution
Results showed that no any sign of phase separation and precipitation 
after dilution of  formulations with water and 0.1 N HCl.
Assessment of Efficiency of self-emulsification
All three formulations of liquid SMEDDS rapidly formed clear and 
slightly bluish microemulsion within 1 min. Hence, as per the grading 
system explained by Khoo et al. [17], all formulations were passed this 
test as per Grade A.
Percentage transmittance, globule size, zeta potential, and 
viscosity
Percentage transmittance of reconstituted liquid SMEDDS of all batches 
was found to be in between 89.4±0.52 and 92.30±0.64. Globule size 
was found to be between 0.189 and 0.246 µm. Zeta potential of liquid 
SMEDDS was found to be −6.8–−9.7 mV. The viscosity of all formulations 
was found to be in between 20.14±1.2 and 26.32±0.98 cps.
Dye solubilization test and cloud point measurement
Dye solubilization test showed that rapid incorporation of the water-
soluble dye (eosin) into the system which indicates that the continuous 
phase was water; hence, the type of microemulsion formed was found 
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to be of o/w type. The cloud point of prepared liquid SMEDDS was found 
to be >80°C for all formulations, which indicate that microemulsion will 
be stable at physiological temperature without risk of phase separation.
Micromeritic properties and drug content of S-SMEDDS
Micromeritic properties such as angle of repose, bulk and tapped 
density, compressibility index, and Hausner ratio and drug content 
of S-SMEDDS are shown in Table 2. Results showed that prepared 
S-SMEDDS shows good flow properties and drug content.
Reconstitution properties of S-SMEDDS
Percentage transmittance, globule size, and zeta potential
The results of percentage transmittance, globule size, and zeta potential 
are summarized in Table 3. The results of percentage transmittance 
indicate that reconstituted S-SMEDDS of DCN was found to be clear. 
Globule size and zeta potential of batch DCN-S3 are shown in Figs. 3 
and 4, respectively.
In vitro dissolution study
Cumulative percentage drug release of all batches of the DCN S-SMEDDS 
and plain DCN in phosphate buffer pH 6.8 with 0.03% SLS is shown 
in Fig. 5. S-SMEDDS formulations showed that >95% of drug release 
within 20 min. While plain DCN shows 28.45% drug release after 
Fig. 3: Globule size of reconstituted solid self-microemulsifying 
drug delivery system of batch diacerein-S3
Fig. 4: Zeta potential of reconstituted solid self-microemulsifying 
drug delivery system of batch diacerein-S3
Table 2: Micromeritic properties and drug content of DCN S-SMEDDS
Formulation Angle of 
repose
Bulk density  
(g/mL)








DCN-S1 20.02±1.25 0.520±0.03 0.598±0.03 13.04±0.04 1.15±0.04 95.28±2.85
DCN-S2 19.52±2.32 0.517±0.04 0.646±0.03 15.52±0.04 1.18±0.03 98.67±1.89
DCN-S3 18.86±1.08 0.642±0.02 0.723±0.04 11.20±0.02 1.12±0.01 98.86±1.24
DCN: Diacerein, S-SMEDDS: Solid self-microemulsifying drug delivery system
Table 3: Percentage transmittance, globule size, and zeta 
potential of S-SMEDDS




DCN-S1 92.32±2.78 0.276 −7.12
DCN-S2 94.76±3.12 0.277 −8.56
DCN-S3 95.45±1.82 0.271 −16.18
DCN: Diacerein, S-SMEDDS: Solid self-microemulsifying drug delivery system
Fig. 5: Cumulative percentage drug release of solid self-
microemulsifying drug delivery system and plain diacerein
Fig. 6: Fourier transform infrared spectra of A: Plain diacerein 
(DCN), B: DCN:Neusilin US2 physical mixture, C: S-SMEDDS
Fig. 7: Scanning electron microscopy of solid self-
microemulsifying drug delivery system of batch diacerein-S3
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20 min. It indicates that drug releases from S-SMEDDS were found to be 
significantly higher as compared to plain DCN.
FTIR study of S-SMEDDS
FTIR spectrum of DCN, DCN:Neusilin US2 physical mixer, and S-SMEDDS 
of batch DCN-S3 is shown in Fig. 6. Deformation of characteristic peaks 
of DCN in S-SMEDDS may be due to the formation of the amorphous 
state of DCN.
SEM
Fig. 7 shows SEM of S-SMEDDS formulation of batch DCN-S3. This shows 
that S-SMEDDS appeared as smooth-surfaced particles, indicating 
liquid SMEDDS is adsorbed or coated inside the pores of Neusilin US2.
CONCLUSION
The study concluded that prepared liquid SMEDDS was 
thermodynamically stable with good self-emulsification efficiency 
and having globule size in the micrometer range. Liquid SMEDDS 
can effectively be converted into S-SMEDDS by adsorption technique 
using Neusilin US2 as a solid carrier. From reconstitution properties of 
S-SMEDDS, it can be said that there is no effect on self-emulsification 
ability and globule size after conversion of liquid SMEDDS into solid. 
FTIR study showed that there is no significant interaction between 
DCN and Neusilin US2. SEM showed that spherical S-SMEDDS can be 
obtained which can be filled into a capsule or compressed in to tablet. 
Cumulative percentage drug release was found to be much higher than 
that of plain DCN. It may be due to an increase in solubility of the drug. 
Hence, the study concluded that solubility, dissolution, and, hence, 
bioavailability of poorly water-soluble drug like DCN can be increased 
by formulating S-SMEDDS.
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